A
Abolfazl Akbarzadeh
Researcher at Tabriz University of Medical Sciences
Publications - 270
Citations - 16170
Abolfazl Akbarzadeh is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: Drug delivery & Cancer. The author has an hindex of 50, co-authored 253 publications receiving 11256 citations. Previous affiliations of Abolfazl Akbarzadeh include University of Tabriz & Education and Research Network.
Papers
More filters
Journal ArticleDOI
A study on the synthesis of [Fe,B]-MFI zeolites using hydrothermal method and investigation of their properties
TL;DR: In this paper, the effect of several parameters including gel composition and pH on the crystallization of MFI-type zeolites with boron and iron in their framework was investigated.
Journal ArticleDOI
Nanomaterials toxin contamination in laboratories and potential harmful effects of their products: a review
Abolfazl Akbarzadeh,Majid Mohammadhosseini,Azam Jafari Najaf Abadi,Arash Hasanzadeh,Elham Abasi,Seyed Mohsen Aberoumandi,Yunes Panahi +6 more
TL;DR: The latest nanotechnological advances propose that nanoparticles have been predictable to be used in different fields and the study of these nanosized material toxicities in the blood, brain, skin, liver, etc. seems to be necessary.
Journal ArticleDOI
The effect of Dimethyl Sulfoxide on hepatogenic differentiation of Mesenchymal Stem Cells
Effat Alizadeh,Nosratollah Zarghami,Mohammad Reza Baghaban Eslaminejad,Abolfazl Akbarzadeh,Shahrbano Jahangir,Abolfazl Barzegar,Shahryar Hahemzadeh,Abolghasem Mohammadi +7 more
TL;DR: DMSO catalyzes hepatic differentiation of AT-MSCs characterized by rapid changes in morphology, higher expression of hepatic marker gene (AFP) in both mRNA and protein level and increased transcriptional levels of other hepatic genes including CK18, HNF4a, and HNF6 in DMSO treated groups.
Journal Article
Targeting HSP90 Gene Expression with 17-DMAG Nanoparticles in Breast Cancer Cells.
TL;DR: PLGA-PEG-17DMAG complexes can be more effective than free 17DMAG in down-regulating of HSP90 expression, at the saesm time exerting more potent cytotoxic effects and could be a superior carrier for this type of hydrophobic agent.
Journal ArticleDOI
Adverse Effects of Vincristine Chemotherapy on Cell Changes in Seminiferous Tubules and Cetrorelix GnRH Antagonist Inhibitory Effects in Mice
TL;DR: The cetrorelix antagonist (GnRH) could largely prevent side effects of vincristine administration regarding seminiferous tubules, according to the results.